Inventor · disambiguated record
Yung-Hsiang Kao
Also filed as: KAO YUNG HSIANG
19 granted patents·7 pending applications·407 citations·filing 2005–2024
96Inventor score
Top patents by PatentIndex Score
26 records- 0198US7560111B2HER2 antibody compositionGENENTECH INC·Filed 2005·Granted Jul 14, 2009·122 cites·12 claims
- 0297US12098211B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2023·Granted Sep 24, 2024·2 cites·14 claims
- 0397US11999791B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2023·Granted Jun 4, 2024·6 cites·43 claims
- 0497US11987638B1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2024·Granted May 21, 2024·4 cites·30 claims
- 0597US11976127B1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2023·Granted May 7, 2024·4 cites·28 claims
- 0697US11639395B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2020·Granted May 2, 2023·8 cites·17 claims
- 0797US11078294B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2020·Granted Aug 3, 2021·11 cites·8 claims
- 0897US10906986B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2020·Granted Feb 2, 2021·12 cites·9 claims
- 0997US10808037B1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2020·Granted Oct 20, 2020·13 cites·9 claims
- 1097US10759866B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2019·Granted Sep 1, 2020·13 cites·9 claims
- 1197US7879325B2HER2 antibody compositionGENENTECH INC·Filed 2009·Granted Feb 1, 2011·76 cites·6 claims
- 1296US12173080B1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2024·Granted Dec 24, 2024·1 cites·10 claims
- 1396US12145997B2Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2024·Granted Nov 19, 2024·1 cites·8 claims
- 1496US11987637B1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2024·Granted May 21, 2024·1 cites·30 claims
- 1596US8241630B2HER2 antibody compositionKAO YUNG-HSIANG·Filed 2011·Granted Aug 14, 2012·63 cites·2 claims
- 1695US8574869B2Prevention of disulfide bond reduction during recombinant production of polypeptidesKAO YUNG-HSIANG·Filed 2012·Granted Nov 5, 2013·37 cites·10 claims
- 1794US12145998B2Pertuzumab variants and evaluation thereofGENENTECH INC·Filed 2022·Granted Nov 19, 2024·2 cites·3 claims
- 1893US9969811B2Pertuzumab variants and evaluation thereofGENENTECH INC·Filed 2017·Granted May 15, 2018·15 cites·2 claims
- 1993US2025243291A1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2024·Application pending·0 cites
- 2092US9815904B2Pertuzumab variants and evaluation thereofGENENTECH INC·Filed 2014·Granted Nov 14, 2017·16 cites·15 claims
- 2188US2025084181A1Pertuzumab variants and evaluation thereofGENENTECH INC·Filed 2024·Application pending·0 cites
- 2270US2020157238A1Pertuzumab variants and evaluation thereofGENENTECH INC·Filed 2019·Application pending·0 cites
- 2367US2017313780A1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2017·Application pending·0 cites
- 2467US2009053786A1Prevention of disulfide bond reduction during recombinant production of polypeptidesKAO YUNG-HSIANG·Filed 2008·Application pending·0 cites
- 2566US2014128575A1Prevention of disulfide bond reduction during recombinant production of polypeptidesGENENTECH INC·Filed 2013·Application pending·0 cites
- 2666US2019345258A1Pertuzumab variants and evaluation thereofGENENTECH INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yung-Hsiang Kao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →